Anxiety Disorders Completed Phase 2 / 3 Trials for Venlafaxine (DB00285)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00248612Psychosocial and Medication Treatment for Anxiety in AlcoholismTreatment